Last reviewed · How we verify

Beijing Chaoyang District Centre for Disease Control and Prevention — Portfolio Competitive Intelligence Brief

Beijing Chaoyang District Centre for Disease Control and Prevention pipeline: 4 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 1 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
the second batch vaccine the second batch vaccine marketed
the third batch vaccine the third batch vaccine marketed vaccine Immunology
the first batch vaccine the first batch vaccine marketed Immunology
two doses enterovirus 71 vaccine two doses enterovirus 71 vaccine marketed inactivated viral vaccine Enterovirus 71 viral antigens Infectious Disease / Immunology
one dose test vaccine one dose test vaccine phase 3 Infectious Disease

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Sinovac Biotech Co., Ltd · 2 shared drug classes
  2. Centers for Disease Control and Prevention · 2 shared drug classes
  3. International Vaccine Institute · 2 shared drug classes
  4. Sanofi Pasteur, a Sanofi Company · 2 shared drug classes
  5. Sinovac Research and Development Co., Ltd. · 2 shared drug classes
  6. Zhejiang Provincial Center for Disease Control and Prevention · 2 shared drug classes
  7. Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · 1 shared drug class
  8. Alba Maria Ropero · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Beijing Chaoyang District Centre for Disease Control and Prevention:

Cite this brief

Drug Landscape (2026). Beijing Chaoyang District Centre for Disease Control and Prevention — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-chaoyang-district-centre-for-disease-control-and-prevention. Accessed 2026-05-17.

Related